Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Simulations Plus Inc (SLP)

Simulations Plus Inc (SLP)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Simulations Plus and the University of Pittsburgh Drug Discovery Institute Receive SBIR Grant Funding for Large Molecule Safety Collaboration

Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today announced that its DILIsym Services (DSS) division...

SLP : 71.72 (+0.15%)
Simulations Plus to Participate in BTIG Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Conference

Simulations Plus, Inc. (Nasdaq: SLP), a premier provider of simulation and modeling software and consulting services for pharmaceutical discovery and development, today announced that Shawn O'Connor, chief...

SLP : 71.72 (+0.15%)
Simulations Plus Releases GastroPlus(R) Version 9.8.1

Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation solutions for the pharmaceutical, biotechnology, chemical, and consumer goods industries, today announced that it has...

SLP : 71.72 (+0.15%)
Simulations Plus Enters Agreement with Distributor in China

Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation solutions for the pharmaceutical, biotechnology, chemical, and consumer goods industries, today announced that it has...

SLP : 71.72 (+0.15%)
Simulations Plus Expands Marketing and Sales Operations in South America Through Partnership with the Institute of Pharmaceutical Sciences

Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation solutions for the pharmaceutical, biotechnology, chemical, and consumer goods industries, today announced that it has...

SLP : 71.72 (+0.15%)
Simulations Plus Awards Infrastructure Improvement Grant to Makerere University Department of Pharmacology and Therapeutics

Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of population pharmacokinetic and pharmacodynamic modeling and simulation services, today announced that its Cognigen division has awarded a grant...

SLP : 71.72 (+0.15%)
Simulations Plus (SLP) Stock Down Despite Q1 Earnings Beat

Simulations Plus (SLP) fiscal first-quarter results reflect solid software and service revenue growth. However, coronavirus crisis affected renewals.

NVDA : 548.58 (+3.06%)
AAPL : 121.26 (+0.22%)
SLP : 71.72 (+0.15%)
GOOGL : 2,021.91 (+0.30%)
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Simulations Plus, Inc. - SLP

New York, New York--(Newsfile Corp. - January 12, 2021) -  Levi & Korsinsky announces it has commenced an investigation of Simulations Plus, Inc. (NASDAQ: SLP) concerning possible breaches of fiduciary...

SLP : 71.72 (+0.15%)
Simulations Plus to Present at 23rd Annual Needham Virtual Growth Conference

Simulations Plus, Inc. (Nasdaq: SLP), a premier provider of simulation and modeling software and consulting services for pharmaceutical discovery and development, today announced that chief executive officer...

SLP : 71.72 (+0.15%)
Simulations Plus Enters New Funded Collaboration to Improve Lung Exposure Models for Pulmonary Infection Treatments

Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation solutions for the pharmaceutical, biotechnology, chemical, and consumer goods industries, today announced that it has...

SLP : 71.72 (+0.15%)
Simulations Plus (SLP) Q1 Earnings and Revenues Top Estimates

Simulations Plus (SLP) delivered earnings and revenue surprises of 9.09% and 1.35%, respectively, for the quarter ended November 2020. Do the numbers hold clues to what lies ahead for the stock?

SLP : 71.72 (+0.15%)
Simulations Plus: Fiscal 1Q Earnings Snapshot

LANCASTER, Calif. (AP) _ Simulations Plus Inc. (SLP) on Monday reported fiscal first-quarter earnings of $2.5 million.

SLP : 71.72 (+0.15%)
Simulations Plus, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / January 11, 2021 / Simulations Plus, Inc. (NASDAQ:SLP) will be discussing their earnings results in their 2021 First Quarter Earnings call to be held on January 11, 2021 at...

SLP : 71.72 (+0.15%)
Simulations Plus Reports Record First Quarter FY2021 Financial Results

--Board of Directors announces quarterly dividend of $0.06 per share

SLP : 71.72 (+0.15%)
Simulations Plus (SLP) to Post Q1 Earnings: What's in Store?

Simulations Plus (SLP) fiscal first-quarter results are likely to reflect gains from solid uptick in modeling and simulations workflow platform for drug development across pharma and biotech industries....

AVT : 38.07 (+1.98%)
MXIM : 93.17 (+1.61%)
APH : 125.68 (+0.38%)
SLP : 71.72 (+0.15%)
Simulations Plus Enters New Funded Collaboration to Enhance Top-Rated GastroPlus(R) ACAT(TM) Model for Oral Absorption of Peptides

Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation solutions for the pharmaceutical, biotechnology, chemical, and consumer goods industries, today announced that it has...

SLP : 71.72 (+0.15%)
Simulations Plus Sets Date for First Quarter Fiscal Year 2021 Earnings Release and Conference Call

Simulations Plus, Inc. (Nasdaq: SLP), announced today that it will report its financial results for the first quarter of fiscal year 2021, ended November 30, 2020, after the close of the financial markets...

SLP : 71.72 (+0.15%)
SLP Crosses Above Average Analyst Target

In recent trading, shares of Simulations Plus Inc. have crossed above the average analyst 12-month target price of $72.50, changing hands for $73.21/share.

SLP : 71.72 (+0.15%)
3 Skyrocketed Software Stocks That Might Lose Sheen in 2021

We discuss three software stocks -- COUP, NUAN and SLP -- which might not sustain market beating run in 2021, owing to persistent macroeconomic weakness across SMBs induced by coronavirus outbreak.

MSFT : 232.38 (+1.48%)
ORCL : 64.51 (-1.21%)
SAP : 123.35 (-0.27%)
NUAN : 44.60 (+3.67%)
CDNS : 141.09 (+2.22%)
SLP : 71.72 (+0.15%)
COUP : 346.26 (+2.94%)
Simulations Plus Publishes its Inaugural Environmental, Social and Governance (ESG) Report

Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation solutions for the pharmaceutical, biotechnology, chemicals, and consumer goods industries, today announced that it has...

SLP : 71.72 (+0.15%)

Van Meerten Stock Picks

5 Great Small Caps
Summary 100% technical buy signals.
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

Barchart Futures Commentary

Barchart Futures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar